Ozempic, Cetaphil Makers Warn of Impact From Trump Tariffs
The European makers of Ozempic for diabetes and Cetaphil for dry skin said they would feel an impact from President Donald ...
World Trademark Review2d
Bombay High Court clamps down on wilful contempt in pharmaceutical infringement dispute
In a case involving well-known anti-allergy drug Allegra, the Bombay High Court has imposed a fine on the defendants for ...
Piri launches ‘strongest ever’ hay fever tablets
Allergy care brand Piri has added Pirilieve Hayfever Relief Tablets containing fexofenadine hydrochloride – an active ...
I Went to the Health Industry’s PR Awards. Luigi Mangione Wasn’t the Only One Haunting the Night.
Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...
JD Supra12d
FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
Pharmaceutical Technology18d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
In addition, Opella develops allergy treatment Allegra (fexofenadine) and irritable bowel syndrome (IBS) relief medicine Buscopan (hyoscine butylbromide), among others. Sales in the business totalled ...
Indiatimes25d
Thunderbolts*: What we know about release date and cast
In 2024, Marvel had a quieter release schedule, with one feature film and three Disney+ series. Despite fewer releases, the studio achieved significant success.